Deutsche Bank set a €49.00 ($60.49) target price on Carl Zeiss Meditec (ETR:AFX) in a report released on Tuesday morning. The firm currently has a neutral rating on the stock.

Several other analysts have also recently weighed in on the stock. Berenberg Bank set a €48.00 ($59.26) price objective on shares of Carl Zeiss Meditec and gave the company a buy rating in a research report on Friday, December 8th. Commerzbank set a €42.00 ($51.85) price objective on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research report on Friday, December 8th. DZ Bank reiterated a sell rating on shares of Carl Zeiss Meditec in a research report on Thursday, October 19th. set a €52.00 ($64.20) target price on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research report on Friday, November 10th. Finally, Independent Research set a €54.00 ($66.67) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Friday, December 8th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company. The company presently has an average rating of Hold and an average price target of €52.88 ($65.28).

Shares of Carl Zeiss Meditec (ETR:AFX) opened at €49.30 ($60.86) on Tuesday. The firm has a market cap of $4,370.00 and a price-to-earnings ratio of 32.65. Carl Zeiss Meditec has a 52-week low of €36.56 ($45.14) and a 52-week high of €55.25 ($68.21).

ILLEGAL ACTIVITY WARNING: This piece was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be read at https://theolympiareport.com/2018/02/14/carl-zeiss-meditec-afx-given-a-49-00-price-target-at-deutsche-bank.html.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.